MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCLA
- Dates
- study startedstudy ends around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Eli Lilly and Company
- Links
- A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
- ID
- NCT06586515
- Phase
- Phase 1 research study
- Study Type
- Interventional
- Participants
- Expecting 570 study participants
- Last Updated